Physician profile
Jorge Andrade
NPI 1942261490
$51,031.86
in general payments reported to CMS, 2019-2025
61 companies · $3,615 in 2025
The $3,615 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $17K · 2021: $8,643 · 2022: $1,536 · 2023: $2,905 · 2024: $4,429 · 2025: $3,615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $45.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,904.30 |
| Education | $45.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11,920.27 | 2019-2021 | |
| Amgen INC. | $10,301.16 | 2019-2025 | Repatha, Otezla, Evenity |
| Astrazeneca Pharmaceuticals LP | $4,850.31 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $4,769.42 | 2019-2025 | |
| Abbvie INC. | $4,087.98 | 2019-2025 | Vraylar, Ubrelvy, Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $2,252.80 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $1,880.30 | 2019-2021 | |
| Novo Nordisk INC | $1,087.14 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $1,005.46 | 2019-2025 | |
| Esperion Therapeutics, INC. | $616.00 | 2020-2025 | Nexletol, Nexlizet |
| Ardelyx, INC. | $586.77 | 2023-2025 | Ibsrela |
| Boehringer Ingelheim Pharmaceuticals, INC. | $586.15 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $579.05 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Otsuka America Pharmaceutical, INC. | $535.27 | 2023-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $469.55 | 2021-2025 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $463.06 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $412.53 | 2019-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $409.64 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $369.22 | 2019-2025 | Verquvo, Gardasil 9, Belsomra |
| Phathom Pharmaceuticals, INC. | $346.72 | 2023-2025 | Voquezna |
| Lundbeck LLC | $264.80 | 2020-2025 | Rexulti |
| Abbott Laboratories | $225.10 | 2019-2024 | Freestyle Libre 3 |
| Corcept Therapeutics | $215.44 | 2024-2025 | Korlym |
| Nestle Healthcare Nutrition INC. | $200.76 | 2020-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $199.17 | 2021-2025 | Caplyta |
| Lexicon Pharmaceuticals, INC. | $199.07 | 2023-2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $191.18 | 2020-2025 | Onpattro |
| Aimmune Therapeutics, INC. | $177.32 | 2024-2025 | Zenpep, Vowst |
| Mylan Specialty L.P. | $172.07 | 2020-2024 | Yupelri |
| Sanofi-Aventis U.S. LLC | $166.52 | 2019-2025 | |
| Verona Pharma, INC. | $144.45 | 2025 | Ohtuvayre |
| Teva Pharmaceuticals USA, INC. | $124.28 | 2019-2025 | Austedo Xr, Austedo Xr |
| Sumitomo Pharma America, INC. | $120.29 | 2023-2025 | Gemtesa |
| Biodelivery Sciences International, INC. | $112.79 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $108.51 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $62.48 | 2025 | |
| Biogen, INC. | $61.77 | 2021-2025 | Skyclarys |
| Vertex Pharmaceuticals Incorporated | $61.08 | 2025 | |
| Vanda Pharmaceuticals INC. | $53.27 | 2021 | |
| Sunovion Pharmaceuticals INC. | $51.74 | 2019-2020 | |
| Axsome Therapeutics, INC. | $49.41 | 2023 | Auvelity |
| Viiv Healthcare Company | $45.33 | 2024 | Apretude |
| Alk-Abello, INC | $44.83 | 2023-2025 | Neffy, Grastek, Ragwitek |
| Paratek Pharmaceuticals, INC. | $38.60 | 2024-2025 | Nuzyra |
| Xeris Pharmaceuticals, INC. | $37.79 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $36.10 | 2019-2020 | |
| Exact Sciences Corporation | $35.86 | 2025 | The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $35.51 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $29.98 | 2019-2025 | Zoryve |
| Amarin Pharma, INC. | $29.06 | 2019-2020 | |
| Hologic Sales and Service, LLC | $24.13 | 2025 | Aptima, Thinprep 2000 Processor |
| Smith+Nephew, INC. | $23.88 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $23.87 | 2021 | |
| Halozyme INC | $20.71 | 2023 | |
| Inspire Medical Systems, INC. | $20.04 | 2025 | Inspire |
| Corium, LLC | $18.70 | 2023 | Azstarys |
| Dexcom, INC. | $17.11 | 2024 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $17.04 | 2023 | Nocdurna, Tlando, Xyosted |
| Shield Therapeutics INC | $16.18 | 2025 | |
| Lucid Diagnostics INC. | $15.88 | 2023 | |
| Sanofi Pasteur INC. | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Andrade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.